Buscar resultados de ensayos clínicos
Polycystic Kidney Diseases - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2011-10-11 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: A Randomised Feasibility Trial of High Water Intake in Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2016-09-18 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2006-12-20 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2011-06-20 Intervenciones:
|
Completed |
Nombre del estudio: Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Fecha: 2006-06-22 Intervenciones:
|
Recruiting |
Nombre del estudio: The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2014-04-28 Intervenciones:
|
Recruiting |
Nombre del estudio: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease Condición: Polycystic Kidney Disease Fecha: 2015-10-30 Intervenciones:
|
Completed |
Nombre del estudio: Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2008-09-24 Intervenciones: Other: Water prescription Water prescription in 12 to 16 equally divided doses |
Terminated |
Nombre del estudio: Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Fecha: 2010-10-12 Intervenciones:
|
Completed |
Nombre del estudio: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001] Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2009-02-09 Intervenciones: Drug: OPC-41061 orally administered at 15 mg twice daily (morning and evening) for a maximum of 3 years. |